Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

3'-OH-THC3'-Hydroxy-Δ9-tetrahydrocannabinol

THC metabolite hydroxylated on the side chain; more active than THC in animals.

Level of detail

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

C₂₁H₃₀O₃

CID 101594562

Family
Metabolite
Molar mass
330.46 g/mol

Updated on

In plain terms

3'-hydroxy-THC is a transformed form of THC, oxidised on its side chain. It was described in animals, first in the lung. In tests in mice and dogs, it proved more active than THC itself.

Receptors and activity

    Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

    Pharmacology

    3'-hydroxy-Δ9-tetrahydrocannabinol is a Δ9-THC metabolite hydroxylated on the third carbon of the pentyl chain. Widman et al. (1975) isolated it, together with 4'-hydroxy-THC, as one of the two major metabolites formed by the perfused dog lung, whereas liver microsomes produced only small amounts. Handrick et al. (1982) found it 2 to 3 times more effective than Δ9-THC in behavioural tests in mice and dogs. The hydroxylation creates a stereocentre: Martin et al. (1984) showed that the S enantiomer is markedly more potent than the R on hypoactivity in mice, static ataxia in dogs and Δ9-THC discrimination in rats, and more active than Δ9-THC, whereas the two enantiomers were equivalent on hypothermia. The authors conclude that metabolism can activate or inactivate Δ9-THC depending on the metabolite formed. No affinity measurement at CB1 or CB2 receptors was found.

    History

    Source
    No occurrence in the plant is documented. 3'-OH-THC is a Δ9-THC metabolite hydroxylated on the pentyl chain, described in animals: a major metabolite in the perfused dog lung and a minor product of dog liver microsomes (Widman et al. 1975).

    Metabolic pathway

    No plant pathway. The molecule results from hydroxylation of the third carbon of the pentyl chain of Δ9-THC. In the dog, this route dominates in the perfused lung, whereas liver microsomes mainly form derivatives hydroxylated at 6 (terpenoid numbering) and at 7 (Widman et al. 1975). The enzymes responsible in humans were not found in the sources consulted.

    Classification

    Family, origin and source verification

    Family

    Metabolite

    Chemistry

    C5 side chain

    Parent molecule

    Δ9-THC

    Active metabolite.

    Verification

    Every fact on this entry was checked against its primary sources on 20 October 2026.

    Wikipedia (English)

    3'-Hydroxy-THC (new tab)

    Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.

    References

    Identifiers

    Names

    Common name
    3'-Hydroxy-Δ9-tetrahydrocannabinol
    IUPAC name
    (6aR,10aR)-3-(3-hydroxypentyl)-6,6,9-trimethyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol
    Other names
    3'-hydroxy-THC · 3'-OH-Δ9-THC

    Identifiers

    Formula
    C₂₁H₃₀O₃
    InChIKey
    GWSPOZKXWMVVEN-YJEKIOLLSA-N
    SMILES
    CCC(CCC1=CC(=C2[C@@H]3C=C(CC[C@H]3C(OC2=C1)(C)C)C)O)O

    Machine-readable entry (JSON)

    LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.